4
Changes in Ownership
DiaMedica Therapeutics Inc. Filed Acc 0001235802-22-000024
Options or other derivatives
- Chief Commercial Officer acquired 165,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Cundari Dominic R Chief Commercial Officer | 2022-02-01 | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | D | ||
| Cundari Dominic R Chief Commercial Officer | 2022-02-01 | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | D | ||
Loading xslF345X03/primary_doc.xml…